NCT04516239

Brief Summary

The goal of this double-blind prospective randomized study is to compare subjective outcome measures and gait parameters between conventional THA using large diameter femoral heads and total hip resurfacing

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2005

Longer than P75 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
12.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 18, 2020

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

August 12, 2020

Last Update Submit

March 12, 2021

Conditions

Keywords

Metal-MetalLarge Diameter Head Total Hip ArthroplastyHip Resurfacing

Outcome Measures

Primary Outcomes (3)

  • Implant revisions

    Implant revisions rate will be compared between groups.

    Preoperative to 15 years

  • Reasons of revisions

    Reasons of revisions will be categorized and compared between groups.

    Preoperative to 15 years

  • Adverse events

    Adverse events will be categorized and compared between groups.

    Preoperative to 15 years

Secondary Outcomes (8)

  • Patient reported outcome measures (PROMs) : Womac

    Preoperative to 15 years

  • Patient reported outcome measures (PROMs) : UCLA activity

    Preoperative to 15 years

  • Patient reported outcome measures (PROMs) : Forgotten Joint

    Preoperative to 15 years

  • Whole blood chromium metal ions levels

    Preoperative to 15 years

  • Whole blood cobalt metal ions levels

    Preoperative to 15 years

  • +3 more secondary outcomes

Study Arms (2)

LDH THA

ACTIVE COMPARATOR

large diameter head total hip arthroplasty

Device: THA

HR

ACTIVE COMPARATOR

metal-on-metalhip resurfacing

Device: HR

Interventions

THADEVICE

Three surgeons performed the surgeries through a posterior surgical approach in both groups. The fascia lata was opened and the gluteus maximus was split in line with its muscle fibers. The short external rotators were released from the greater trochanter. A posterior capsulotomy was performed and the hip dislocated. For the THA, the standard techniques proposed by the manufacturer for insertion of the stem were followed. Neck sleeve adapters and three different prosthetic neck-shaft angles (125, 135, and 145) were available to adjust leg length and femoral offset with the large-diameter head THA system.

LDH THA
HRDEVICE

Three surgeons performed the surgeries through a posterior surgical approach in both groups. The fascia lata was opened and the gluteus maximus was split in line with its muscle fibers. The short external rotators were released from the greater trochanter. A posterior capsulotomy was performed and the hip dislocated. In the HR group, the capsulotomy was completed circumferentially, and the gluteus tendinous insertion on the femur was released in all men, but only when needed in women, to improve femur mobilization.

HR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with degenerative disease of the hip in need for total hip or total hip resurfacing arthroplasty
  • Patient who understands the study protocol and willing to comply with the planned clinical follow-up
  • Patient can give informed consent

You may not qualify if:

  • Age older than 65 years old or younger than 18 years old
  • Charnley class B (both hip diseased) or C (polyarticular disease) patients
  • Spinal or lower limb disease other than the degenerated hip that could influence gait and walking performance
  • Neuromuscular disorder
  • Known or suspected metal allergy
  • Pregnancy
  • Renal insufficiency
  • Known or suspected osteopenia or osteoporosis of the hip

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kostretzis L, Lavigne M, Kiss MO, Shahin M, Barry J, Vendittoli PA. Despite higher revision rate, MoM large-head THA offers better clinical scores than HR: 14-year results from a randomized controlled trial involving 48 patients. BMC Musculoskelet Disord. 2021 Apr 30;22(1):400. doi: 10.1186/s12891-021-04286-6.

Related Links

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient will be informed of the randomization group, 6 months after surgery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a prospective randomized clinical trial with two parallel treatment groups. At the preoperative teaching session, the study objectives and the risks and benefits of surgery will be explained to the patient by the research assistant or the surgeon in order to obtain consent. A randomization table will be generated by the SPSS 10 software and sealed numerated envelopes will be assigned to each patient entering the study. A research assistant will coordinate the study and data collection.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedist

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 18, 2020

Study Start

September 1, 2005

Primary Completion

September 1, 2007

Study Completion

July 1, 2020

Last Updated

March 16, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share